BillionToOne (BLLN) Non-Current Deffered Revenue (2025)
BillionToOne (BLLN) posted Non-Current Deffered Revenue of $1.3 million for Q4 2025.
BillionToOne (BLLN) Non-Current Deffered Revenue (2025) Analysis & Trends
BillionToOne has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was little changed at $1.3 million in Q4 2025 per BLLN's latest filing.
- Over five years, Non-Current Deffered Revenue peaked at $1.3 million in Q4 2025 and troughed at $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 32.59 Mn |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | - |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | - |
| 10 | BillionToOne | 4.31 Bn | 3.78 Bn | 79.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Mn |